Valbiotis (XPAR:ALVAL) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALVAL Valbiotis SA XPAR:ALVAL
60 GF Score
Price €0.79
GF Value €1.48
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Valbiotis 5-Year Yield-on-Cost %?

Valbiotis XPAR:ALVAL +1.67% 60 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus rates XPAR:ALVAL with a GF Score™ of 60/100 and a GF Value™ of €1.48 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,174 Consumer Packaged Goods companies, Valbiotis ranks worse than 85178.79% on this metric.

Valbiotis's yield on cost for the quarter that ended in Dec. 2025 was 0.00.


The historical rank and industry rank for Valbiotis's 5-Year Yield-on-Cost % or its related term are showing as below:



XPAR:ALVAL's 5-Year Yield-on-Cost % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.415
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Valbiotis  (XPAR:ALVAL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Valbiotis 5-Year Yield-on-Cost % Related Terms


XPAR:ALVAL vs KHC, GIS, HRL: 5-Year Yield-on-Cost % Comparison

For the Packaged Foods subindustry, Valbiotis's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valbiotis 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Valbiotis's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Valbiotis's 5-Year Yield-on-Cost % falls into.


XPAR:ALVAL
60GF Score
Valbiotis SA XPAR:ALVAL
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valbiotis 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Valbiotis is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Valbiotis (XPAR:ALVAL) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Valbiotis and its competitors. According to the industry distribution chart, Valbiotis ranks #999999 out of 1174 companies in the Consumer Packaged Goods industry.
Is Valbiotis' 5-Year Yield-on-Cost % too high?
Valbiotis' current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Valbiotis ranks #999999 out of 1174 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Valbiotis has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Valbiotis' 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Valbiotis ranks #999999 out of 1174 companies for 5-Year Yield-on-Cost %. This places Valbiotis in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.42, based on 1,174 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Valbiotis and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valbiotis's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valbiotis stock overvalued right now?
Based on GuruFocus' analysis, Valbiotis (XPAR:ALVAL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.48, compared to a current price of €0.79 — trading 46.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Valbiotis' overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Valbiotis (XPAR:ALVAL), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Valbiotis (XPAR:ALVAL) Overvalued in 2026?

Based on GuruFocus' analysis, Valbiotis stock appears to be undervalued. The current stock price of €0.79 is trading 46.6% below its estimated GF Value™ of €1.48. GuruFocus considers Valbiotis to be Possible Value Trap.

Key valuation signals for XPAR:ALVAL:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: €1.48 vs. price of €0.79 (46.6% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the XPAR:ALVAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Valbiotis Business Description

Other Exchanges 8JD:Germany
Address 12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
60GF Score

Get the complete analysis for XPAR:ALVAL

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.79
Price
€1.48
GF Value